Safety of Human Papillomavirus 9-Valent Vaccine: A Meta-Analysis of Randomized Trials

Vaccination against human papillomavirus (HPV) has been progressively implemented in most developed countries for approximately 10 years. In order to increase the protection of the vaccines, a 9-valent vaccine (HPV9) was developed, which provides protection against nine types of the virus. Studies e...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Ana Paula Ferreira, Cobucci, Ricardo Ney Oliveira, da Silva, Janine Medeiros, da Costa Lima, Paulo Henrique, Giraldo, Paulo César, Gonçalves, Ana Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546048/
https://www.ncbi.nlm.nih.gov/pubmed/28812030
http://dx.doi.org/10.1155/2017/3736201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546048/
https://www.ncbi.nlm.nih.gov/pubmed/28812030
http://dx.doi.org/10.1155/2017/3736201

Ejemplares similares